3D Printing of Pharmaceuticals and Drug Delivery Devices
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The process of 3D printing (3DP) was patented in 1986; however, the research in the field of 3DP did not become popular until the last decade. There has been an increasing research into the areas of 3DP for medical applications for fabricating prosthetics, bioprinting and pharmaceutics. This novel method allows the manufacture of dosage forms on demand, with modifications in the geometry and size resulting in changes to the release and dosage behaviour of the product. 3DP will allow wider adoption of personalised medicine due to the diversity and simplicity to change the design and dosage of the products, allowing the devices to be designed specific to the individual with the ability to alternate the drugs added to the product. Personalisation also has the potential to decrease the common side effects associated with generic dosage forms. This Special Issue Editorial outlines the current innovative research surrounding the topic of 3DP, focusing on bioprinting and various types of 3DP on applications for drug delivery as well advantages and future directions in this field of research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Azad, M. A., Olawuni, D., Kimbell, G., Badruddoza, A. Z. M., Hossain, M. S., & Sultana, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020124 · Cited by 356 · cited 1×
“Finally, examined the challenges and opportunities related to pharmaceutical extrusion-based 3Dp [20].”
Background
Cited by
Fused deposition modelling: Current status, methodology, applications and future prospects
Cano-Vicent, A., Tambuwala, M. M., Hassan, S. S., Barh, D., Aljabali, A. A. A., Birkett, M., Arjunan, A., & Serrano-Aroca, Á. (2021) · Additive Manufacturing · doi:10.1016/j.addma.2021.102378 · Cited by 509
Azad, M. A., Olawuni, D., Kimbell, G., Badruddoza, A. Z. M., Hossain, M. S., & Sultana, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020124 · Cited by 356
Stereolithography 3D printing technology in pharmaceuticals: a review
Deshmane, S., Kendre, P., Mahajan, H., & Jain, S. (2021) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2021.1994990 · Cited by 103
The sustainability of emerging technologies for use in pharmaceutical manufacturing
Weaver, E., O’Hagan, C., & Lamprou, D. A. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2093857 · Cited by 70
Poly(caprolactone)-based subcutaneous implant for sustained delivery of levothyroxine
Stewart, S. A., Domínguez-Robles, J., Utomo, E., Picco, C. J., Corduas, F., Mancuso, E., Amir, M. N., Bahar, M. A., Sumarheni, S., Donnelly, R. F., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121011 · Cited by 35
Self-citation
Metadata
- Authors
- Mathew, E., Pitzanti, G., Larrañeta, E., & Lamprou, D. A.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2020-03-15
- Volume
- 12
- Issue
- 3
- Pages
- 266
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W3012173623
- Cited by
- 157
- References
- 1
- FWCI
- 9.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 3D Printing of Pharmaceuticals and Drug Delivery Devices. https://app.cochat.ai/papers/10.3390/pharmaceutics12030266
- The paper
- Mathew, E., Pitzanti, G., Larrañeta, E., & Lamprou, D. A. (2020). 3D Printing of Pharmaceuticals and Drug Delivery Devices. Pharmaceutics. https://doi.org/10.3390/pharmaceutics12030266
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.